World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 May 2016
Main ID:  NCT02448693
Date of registration: 15/05/2015
Prospective Registration: No
Primary sponsor: Parc de Salut Mar
Public title: Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal Resection CROMOPIE
Scientific title: Randomised Tandem Colonoscopy of Narrow Band Imaging (NBI) and White Light Endoscopy in Patients With Endoscopic Piecemeal Mucosal Resection
Date of first enrolment: May 2015
Target sample size: 120
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02448693
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
Spain
Contacts
Name:     Fausto Riu, MD
Address: 
Telephone:
Email:
Affiliation:  Parc de Salut Mar
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients over 18 years old who underwent a colonoscopy for any reason in the last 12
month

- Patients with a basal colonoscopy findings: =1 polyp removed in a piecemeal fashion
regardless of the size

Exclusion Criteria:

- Diagnosis of a CRC in the basal colonoscopy

- Subjects who neglect to follow-up

- Subjects who do not accept informed consent

- Subjects with high risk of perforation or complications due to sedation, including
patients with comorbidities (ASA IV-V)

- Inadequate bowel preparation for colonoscopy (defined by Boston Bowel Preparation
Score (BBPS): = 5 total points; or 0-1 points in any of the 3 segments of the colon)



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Colorectal Neoplasms
Intervention(s)
Device: NBI
Device: WLE
Primary Outcome(s)
Number of residual neoplastic tissue detected with both techniques (NBI versus WLE) [Time Frame: less than 1 year after the basal colonoscopy]
Secondary Outcome(s)
Number of accurate detection of residual neoplastic tissue with morphologic features in both groups (NBI and WLE) compared with histopathology [Time Frame: less than 1 year after the basal colonoscopy]
Number of missed lesions on basal colonoscopy [Time Frame: less than 1 year after the basal colonoscopy]
Secondary ID(s)
CROMOPIE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history